期刊文献+

建立局部性家兔肠系膜静脉血栓模型 被引量:2

Establishment of the Model of Local Mesenteric Venous Thrombosis in Rabbits
原文传递
导出
摘要 目的探讨建立局部性家兔肠系膜静脉血栓(MVT)模型的方法。方法于2008年1月,将36只家兔随机均分为3组,肠系膜前静脉局部阻断加静脉分支注射凝血酶,A组80U/mL,B组40U/mL,C组注射生理盐水1mL。观测血栓形成时间、范围和周围静脉血D-二聚体(DD)变化。结果 A、B两组均可建立控制范围内稳定MVT模型,血栓形成时间分别为(15.6±2.0)min和(22.3±2.5)min,两组比较有统计学意义(P<0.001);术前A、B两组DD为(68.4±5.7)ng/mL、(72.7±6.4)ng/mL,血栓形成后为(209.0±24.0)ng/mL、(215.4±17.6)ng/mL,组内比较有统计学意义(P<0.001);C组不形成血栓。结论局部静脉阻断加凝血酶注射法可建立稳定和范围可控的MVT模型,建模前后血浆DD值有一定实验参考价值。 Objective To establish the model of local mesenteric venous thrombosis(MVT)in rabbits.Methods In January 2008,36rabbits were randomly divided into three groups with 12rabbits in each.The anterior mesenteric veins were blocked regionally,and at the same time the rabbits were injected with thrombin 80U/mL through the branches of mesenteric vein in group A,40U/mL in group B,and 1mL normal saline in group C.Time and range of thrombosis were observed,and D-dimer level in peripheral vein was tested.Results Stable MVT model was established in intended region in both group A and B.There was a significant reduction of thrombosis time in group A[(15.6±2.0)minutes]when compared with that in group B[(22.3±2.5)minutes](P〈0.001).The levels of D-dimer in group A two hours after operation[(209.0±24.0)ng/mL]increased significantly compared with that before the operation[(68.4±5.7)ng/mL](P〈0.001);while the same condition was found in group B [(215.4±17.6)ng/mL vs(72.7±6.4)ng/mL](P〈0.001).No thrombus was found in group C.Conclusion Stable MVT model with controllable thrombotic range can be established by regional vein blockade plus thrombin injection.Plasma D-dimer levels before and after model establishment could be as a parameter for assessing the experiment.
出处 《华西医学》 CAS 2010年第10期1827-1830,共4页 West China Medical Journal
关键词 肠系膜 局部性静脉血栓 D-二聚体 动物模型 Mesentery Local venous thrombosis D-dimer Animal model
  • 相关文献

参考文献15

  • 1Rhee RY, Gloviezki P, Mendonea CT, etal. Mesenteric venous thrombosis: still a lethal disease in the 1990[J]. J Vasc Surg, 1994, 20(5): 688-697.
  • 2James AW, Rabl C, Westphalen AC, et al. Portomesenteric venous thrombosis after laparoscopic surgery: a systematie literature review[J]. Arch Surg, 2009, 144(6): 520-526.
  • 3Brunaud L, Antunes L, Adler SC, et al. Acute mesenteric venous thrombosis:Case for nonoperative management[J]. J Vas Surg, 2001, 34(4): 673-679.
  • 4Wang MQ, Guo LP, Lin HY, et al. Transradial approach for transcatheter selective superior mesenteric artery urokinase infusion therapy in patients with acute extensive portal and superior mesenteric vein thrombosis[J]. Cardiovasc Intervent Radiol. 2010, 33(]): 80-89.
  • 5Acosta S, Ogren M, Sternby NH, et al. Mesenteric venous thrombosis with transmural intestinal infarction:a populationbased study[J]. J Vasc Surg, 2005, 41(1) ; 59-63.
  • 6Acosta S, Alhadad A, Svensson P, et al. Epidemiology, risk and prognostic factors in mesenteric venous thrombosis[J]. Br J Surg, 2008, 95(10): 1245-1251.
  • 7Acosta S. Epidemiology of mesenteric vascular disease: clinical implications[J]. Semin Vasc Surg, 2010, 23(1): 4-8.
  • 8Dentali F, Ageno W, Witt D, et al. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study [J].Thromb Haemost, 2009, 102(3):501-504.
  • 9Levi M, Dorffle-Melly J, Johnson GJ, et al. Usefulness and limitations of animal models of venous thrombosis[J]. Thromb Haemost, 2001, 86(5): 1331-1:333.
  • 10Schumacher WA, Bostwick JS, Stewart AB, etal. Effeet of the direct factor Xa inhibitor apixaban in rat models of thrombosis and hemostasis[J]. J Cardiovase Pharmaeol, 2010, 55(6) : 609- 616.

同被引文献33

  • 1张智辉,林少芒,姚燕丹,张皓,张柏根.大鼠后肢深静脉血栓模型的制备与研究[J].现代临床医学生物工程学杂志,2006,12(2):146-148. 被引量:5
  • 2Rhee R Y, Gloviczki P, Mendonca C T, et al. Mesenteric ve- nous thrombosis:still a lethal disease in the 1990[J]. J Vasc Surg, 1994,20(5) : 688-697.
  • 3Brunaud L, Antunes L, Adler S C, et al. Acute mesenteric ve- nous thrombosis:Case for nonoperative management [J] J Vas Surg,2001,34(4) :673-679.
  • 4Aeosta S, Alhadad A, Svensson P, et al. Epidemiology, risk a nd prognostic factors in mesenteric venous thrombosis[J]. Br J Surg,2008,95(10) :1245-1251.
  • 5Acosta S. Epidemiology of mesenteric vascular disease : clinical implications[J]. Semin Vasc Surg, 2010,23 (1) : 4-8.
  • 6Safieddine N, Mamazza J,Common A,et al. Splenic and supe- rior mesenteric artery thrombolytic infusion therapy for acute portal and mesenteric vein thrombosis[J]. Can J Surg, 2007, 50(1):68-69.
  • 7Wang M Q,Guo L P,Lin H Y,et al. Transradial approach for transcatheter selective superior mesenteric artery urokinase infusion therapy in patients with acute extensive portal andsuperior mesenteric vein thrombosis[J]. Cardiovasc Intervent Radiol,2010,33(1) :80-89.
  • 8Dentali F, Ageno W, Witt D, et al. Natural history of mesen- teric venous thrombosis in patients treated with vitamin K an- tagonists., a multi-centre, retrospective cohort study [J] Thromb Haemost, 2009,102(3) :501-504.
  • 9Righini M,Perrier A,De Moerloose P, et al. D-Dimer for ve- nous thromboembolism diagnosis: 20 years later[J]. J Thromb Haemost,2008,6(7) :1059-1071.
  • 10Palareti G, Cosmi B, Legnani C, et al. I-dimer testing to de- termine the duration of anticoagulation therpy[J]. N Engl J Med,2006,355(17) :1780-1789.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部